Press Release

<< Back
Printer Friendly Version View printer-friendly version
Depomed to Present at the UBS Global Healthcare Conference

NEWARK, Calif., May 16, 2017 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that members of senior management will participate in a fireside chat at the 2017 UBS Global Healthcare Conference scheduled for 10:00 am ET (7:00 am PT) on Tuesday, May 23, 2017 in New York, New York.

This presentation will be webcast and can be accessed via the Investor Relations page of the Depomed website at  A recording of the webcasts will be archived for 30 days.

About Depomed

Depomed is a leading specialty pharmaceutical company focused on enhancing the lives of the patients, families, physicians, providers and payors we serve through commercializing innovative products for pain and neurology related disorders. Depomed markets six medicines with areas of focus that include mild to severe acute pain, moderate to severe chronic pain, neuropathic pain, migraine and breakthrough cancer pain. Depomed is headquartered in Newark, California. To learn more about Depomed, visit

Investor Contact:

Christopher Keenan
VP, Investor Relations and Corporate Communications

Primary Logo

Depomed, Inc